Z-1451-2022 Class II Terminated

Recalled by LumiraDx — Waltham, MA

FDA device recall Z-1451-2022 was initiated by LumiraDx on Jun 24, 2022 and is designated Class II. Reason for recall: Modification to the LumiraDx SARS-CoV-2 Antibody (Ab) test that was made outside the scope of the approved EUA. The recall status is terminated (terminated May 10, 2024). Affected quantity: 99 units.

Recall details

Product Type
Devices
Report Date
Jul 27, 2022
Initiation Date
Jun 24, 2022
Termination Date
May 10, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
99 units

Product description

LumiraDx SARS-CoV-2 Antibody (Ab) Liquid Quality Control

Reason for recall

Modification to the LumiraDx SARS-CoV-2 Antibody (Ab) test that was made outside the scope of the approved EUA.

Distribution pattern

Domestic: AR, CA, FL, MA, MD, NC, NJ, NV, NY, OK, TN, TX, & WI.

Code information

No UDI codes. Catalog No. L017080109002. Lot No. 2002201428 (Exp. 01-Sept-2022).

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1451-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1451-2022. Report a data issue: hello@regdatalab.com.